212 related articles for article (PubMed ID: 37014531)
1. Variable Bone Phenotypes in Patients with Pseudohypoparathyroidism.
Wang Y; Lu C; Chen X
Curr Osteoporos Rep; 2023 Jun; 21(3):311-321. PubMed ID: 37014531
[TBL] [Abstract][Full Text] [Related]
2. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.
Turan S
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743
[TBL] [Abstract][Full Text] [Related]
3. Genetic basis for resistance to parathyroid hormone.
Levine MA; Germain-Lee E; Jan de Beur S
Horm Res; 2003; 60 Suppl 3():87-95. PubMed ID: 14671404
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
Kruse K; Kracht U; Wohlfart K; Kruse U
Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
[TBL] [Abstract][Full Text] [Related]
5. [Parathyroid and bone. Bone metabolism in hypoparathyroidism].
Okazaki R
Clin Calcium; 2007 Dec; 17(12):1852-7. PubMed ID: 18057660
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic analysis of pseudohypoparathyroidism complicated by hypokalemia: a case report and review of the literature.
Huang S; He Y; Lin X; Sun S; Zheng F
BMC Endocr Disord; 2022 Apr; 22(1):98. PubMed ID: 35410271
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Multiple Families With Single Individuals Affected by Pseudohypoparathyroidism Type Ib (PHP1B) Reveals Only One Novel Maternally Inherited GNAS Deletion.
Takatani R; Molinaro A; Grigelioniene G; Tafaj O; Watanabe T; Reyes M; Sharma A; Singhal V; Raymond FL; Linglart A; Jüppner H
J Bone Miner Res; 2016 Apr; 31(4):796-805. PubMed ID: 26479409
[TBL] [Abstract][Full Text] [Related]
8. Sporadic pseudohypoparathyroidism type-1b with asymptomatic hypocalcemia.
Goto M; Yamamoto Y; Ishii M; Nakamura A; Sano S; Kagami M; Fukami M; Saito R; Araki S; Kubo K; Kawagoe R; Kawada Y; Kusuhara K
Pediatr Int; 2016 Nov; 58(11):1229-1231. PubMed ID: 27882740
[TBL] [Abstract][Full Text] [Related]
9. An update on the clinical and molecular characteristics of pseudohypoparathyroidism.
Levine MA
Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):443-51. PubMed ID: 23076042
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel mutation in pseudohypoparathyroidism type Ia in a Chinese family: A case report.
Tang Y; Zheng F; Lin X; Pan Q; Li L; Li H
Medicine (Baltimore); 2020 May; 99(21):e19965. PubMed ID: 32481259
[TBL] [Abstract][Full Text] [Related]
11. GNAS locus and pseudohypoparathyroidism.
Bastepe M; Jüppner H
Horm Res; 2005; 63(2):65-74. PubMed ID: 15711092
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance.
Laspa E; Bastepe M; Jüppner H; Tsatsoulis A
J Clin Endocrinol Metab; 2004 Dec; 89(12):5942-7. PubMed ID: 15579741
[TBL] [Abstract][Full Text] [Related]
13. The GNAS locus and pseudohypoparathyroidism.
Bastepe M
Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in GNAS epigenetic research of pseudohypoparathyroidism.
Izzi B; Van Geet C; Freson K
Curr Mol Med; 2012 Jun; 12(5):566-73. PubMed ID: 22300135
[TBL] [Abstract][Full Text] [Related]
15. Renal-nonresponsive, bone-responsive pseudohypoparathyroidism. A case with normal vitamin D metabolite levels and clinical features of rickets.
Dabbagh S; Chesney RW; Langer LO; DeLuca HF; Gilbert EF; DeWeerd JH
Am J Dis Child; 1984 Nov; 138(11):1030-3. PubMed ID: 6548601
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Molecular Characteristics of GNAS Inactivation Disorders Observed in 18 Korean Patients.
Han SR; Lee YA; Shin CH; Yang SW; Lim BC; Cho TJ; Ko JM
Exp Clin Endocrinol Diabetes; 2021 Feb; 129(2):118-125. PubMed ID: 31546270
[TBL] [Abstract][Full Text] [Related]
17. Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations.
Elli FM; deSanctis L; Ceoloni B; Barbieri AM; Bordogna P; Beck-Peccoz P; Spada A; Mantovani G
Hum Mutat; 2013 Mar; 34(3):411-6. PubMed ID: 23281139
[TBL] [Abstract][Full Text] [Related]
18. Association of GNAS imprinting defects and deletions of chromosome 2 in two patients: clues explaining phenotypic heterogeneity in pseudohypoparathyroidism type 1B/iPPSD3.
Elli FM; deSanctis L; Maffini MA; Bordogna P; Tessaris D; Pirelli A; Arosio M; Linglart A; Mantovani G
Clin Epigenetics; 2019 Jan; 11(1):3. PubMed ID: 30616679
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in a case of pseudohypoparathyroidism type Ia.
Kırel B; Demiral M; Bozdağ Ö; Karaer K
Turk J Pediatr; 2016; 58(1):101-105. PubMed ID: 27922245
[TBL] [Abstract][Full Text] [Related]
20. Progressive Development of PTH Resistance in Patients With Inactivating Mutations on the Maternal Allele of GNAS.
Usardi A; Mamoune A; Nattes E; Carel JC; Rothenbuhler A; Linglart A
J Clin Endocrinol Metab; 2017 Jun; 102(6):1844-1850. PubMed ID: 28323910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
